Compare conditions

Put any two — or three — conditions side by side, adult or pediatric, to spot the look-alike differences fast, row by row.

BPH and Lower Urinary Tract Symptoms

—

In one line

·Benign prostatic hyperplasia (non-cancerous prostate growth) squeezes the urethra (the tube that drains urine from the bladder), blocking urine flow and causing both trouble emptying (weak stream, hesitancy) and trouble storing (urgency, frequency, waking at night).

—

Normal physiology

·The prostate is a walnut-sized gland that wraps around the urethra just below the bladder. The bladder fills with urine and empties by squeezing its detrusor muscle (the bladder wall muscle) while the urethral sphincter (the valve at the bladder neck) relaxes, so urine flows smoothly through the urethra and out. Picture it like a balloon connected to a garden hose with a valve: the balloon squeezes, the valve opens, and water flows freely.

—

What goes wrong

·Usually one broken thing explains all the weird findings together.

—

Hallmark signs

·Weak urinary stream
·Hesitancy (delay starting urination)
·Intermittency (stop-start urine flow)
·Post-void dribbling
·Sensation of incomplete bladder emptying
·Urinary frequency (going 8 or more times a day)
·Urgency (sudden strong need to urinate)
·Waking at night to urinate (Nocturia) (waking 2 or more times at night to urinate)

—

Red flags · escalate now

·Acute urinary retention (sudden inability to urinate, severe lower belly pain, bladder you can feel above the pubic bone)—needs emergency catheter to drain urine and prevent bladder rupture and kidney damage.
·Visible blood in the urine (hematuria) (urine that looks pink, red, or cola-colored)—can mean bladder cancer, stones, or severe prostate bleeding; needs urgent camera look inside the bladder (cystoscopy) and imaging.
·Recurrent urinary tract infections (2 or more proven infections in 6 months)—shows leftover urine is becoming a pool where bacteria grow; raises risk of kidney infection or bloodstream infection (sepsis).
·Rising creatinine in blood or swollen kidneys on scan (hydronephrosis)—signs the blockage is backing urine up into the kidneys and damaging them; kidney harm can be permanent if not fixed quickly.
·Bladder stones seen on ultrasound or CT—form in stagnant leftover urine and can cause infection, bleeding, or total blockage of urine flow.

—

Workup

·Urinalysis (UA) with microscopy
·Basic metabolic panel (BMP) with serum creatinine and estimated glomerular filtration rate (eGFR)
·Post-void residual (PVR) volume by portable bladder ultrasound or straight catheterization immediately after the patient urinates
·Prostate-specific antigen (PSA) if the patient is expected to live more than 10 years and after shared decision-making discussion
·Renal and bladder ultrasound
·Uroflowmetry (measuring urine flow rate into a special toilet) or urodynamic studies (pressure-flow study with catheters in bladder and rectum)
·Urine culture if urinalysis shows signs of infection
·Serum electrolytes (sodium, potassium, chloride, bicarbonate) if chronic retention is suspected

—

Treatment

·Alpha-1 blocker: tamsulosin 0.4 mg once daily, alfuzosin 10 mg extended-release once daily, or silodosin 8 mg twice daily
·5-alpha reductase inhibitor (5-ARI): finasteride 5 mg once daily or dutasteride 0.5 mg once daily
·Phosphodiesterase-5 inhibitor (PDE5i): tadalafil 5 mg once daily
·Combination therapy: alpha-blocker plus 5-alpha reductase inhibitor (for example, tamsulosin plus finasteride or dutasteride)
·Surgical or minimally invasive intervention: transurethral resection of the prostate (TURP), laser procedures (GreenLight PVP photoselective vaporization, holmium laser enucleation HoLEP), prostatic urethral lift (UroLift), or water-vapor thermal therapy (Rezūm)
·Avoid anticholinergic or antimuscarinic medications (oxybutynin, tolterodine, solifenacin, darifenacin) in men with significant BPH unless PVR is low and bladder outlet obstruction is ruled out; use clean intermittent catheterization if acute urinary retention occurs
·Watchful waiting or active surveillance if symptoms are mild (IPSS below 8) and not bothersome to the patient

—

NCLEX trap

·Weak stream in BPH (the prostate growing bigger and noncancerous) happens because the enlarged prostate pinches the urethra (the tube that carries urine out) shut, NOT because the bladder muscle is weak—at least not at first. An alpha-blocker medicine relaxes the smooth muscle inside the prostate and bladder neck so the channel opens wider. Making the bladder push harder when the exit is already blocked just damages the bladder over time and makes things worse.
·Waking at night to urinate (Nocturia) in BPH is a storage symptom: the bladder wall gets thick and irritable from fighting the obstruction, so it tells the brain to empty even when only partly full—including at night. The kidneys concentrate urine just fine. Treat the prostate blockage and bladder irritation with alpha-blockers (to relax the prostate) and 5-alpha reductase inhibitors (to shrink the gland), not the kidneys.
·Prostate size on finger exam does NOT reliably predict how bad symptoms are in BPH. A man with a slightly bigger prostate can have severe blockage if the gland sits right where it squeezes the urethra, and a man with a large gland may have mild symptoms. Measure symptom severity with the IPSS questionnaire (International Prostate Symptom Score—a checklist of how much urinary problems bother the patient) and post-void residual (how much urine is left in the bladder after peeing), not gland size alone.
·In BPH, a post-void residual above 100 mL suggests real obstruction and that the bladder muscle is straining. While 50 mL may be okay in some people, a rising trend plus worsening symptoms together signal that the blockage is getting worse. Treat based on the whole picture—symptoms, residual volume trend over time, kidney function—not one number by itself.
·Anticholinergics make BPH worse by weakening the bladder muscle's push when the bladder is already struggling to squeeze urine past an obstruction. This can trigger acute urinary retention (sudden complete inability to pee). Use alpha-blockers to relax the prostate and bladder neck, and 5-alpha reductase inhibitors to shrink the gland, BEFORE ever considering anticholinergics—and only if the obstruction is relieved and post-void residual is low.
·Alpha-blockers work within one to two weeks for symptom relief in BPH, but 5-alpha reductase inhibitors take three to six months to shrink the prostate. If symptoms do not improve after a fair trial, try a different alpha-blocker or add a 5-alpha reductase inhibitor for combination therapy. Do not give up on the alpha-blocker class after only one week unless the patient has side effects he cannot tolerate (like dizziness or low blood pressure).

—

Install Maldek by Hill as an app — studies work even offline